|
ZC3H6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20030000383409E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33130000251813E-08 |
| Normal-vs-Stage2 |
3.87399999968174E-07 |
| Normal-vs-Stage3 |
4.07790001766273E-09 |
| Normal-vs-Stage4 |
3.53179999690312E-08 |
| Stage1-vs-Stage2 |
8.617600E-01 |
| Stage1-vs-Stage3 |
1.585640E-01 |
| Stage1-vs-Stage4 |
4.105400E-01 |
| Stage2-vs-Stage3 |
4.429200E-01 |
| Stage2-vs-Stage4 |
6.238600E-01 |
| Stage3-vs-Stage4 |
8.166400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.40810000326397E-08 |
| Normal-vs-AfricanAmerican |
1.517560E-03 |
| Normal-vs-Asian |
1.05220000046202E-07 |
| Caucasian-vs-AfricanAmerican |
2.761600E-01 |
| Caucasian-vs-Asian |
8.742400E-01 |
| AfricanAmerican-vs-Asian |
3.265400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.50430000362456E-08 |
| Normal-vs-Female |
9.19459997028582E-09 |
| Male-vs-Female |
4.746200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.54850000494622E-08 |
| Normal-vs-Age(41-60Yrs) |
4.82669999524177E-08 |
| Normal-vs-Age(61-80Yrs) |
5.64019997373322E-09 |
| Normal-vs-Age(81-100Yrs) |
1.55660000000779E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.986200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.828800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.541800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.584800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.987600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.876180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.581800E-04 |
| Classical-VS-Follicular |
8.851800E-02 |
| Classical-VS-Other |
6.546400E-01 |
| Classical-VS-Normal |
2.75600000043674E-07 |
| Tall-VS-Follicular |
9.442100E-02 |
| Tall-VS-Other |
2.800200E-01 |
| Tall-VS-Normal |
3.04219982538712E-10 |
| Follicular-VS-Other |
9.067200E-01 |
| Follicular-VS-Normal |
3.27939999600346E-08 |
| Other-VS-Normal |
1.772170E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12519999984073E-08 |
| Normal-vs-N1 |
6.77110000291137E-08 |
| N0-vs-N1 |
9.735400E-01 |
|
|
